The Abbreviated Evaluation Process pathway has been developed by the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) of New Zealand.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Canada EU-EMA Europe United Kingdom United States

Evaluation Timeframes: